Reshaping the course
of young lives.
Epilepsy is one of the world’s most common diseases. A rare form of epilepsy in newborns, with frequent seizures beginning in the first days or hours of life, is called KCNQ2 epileptic encephalopathy (KCNQ2-EE).
Our platform is creating hope that investigational Kv7 drugs may control seizures and improve or normalize brain development in children.